Samy I. McFarlane
Dr. Samy I. McFarlane, MD, MPH, MBA, FACP is a distinguished teaching professor of Medicine and Endocrinology and an Associate Dean at the College of Medicine, State University of New York, Downstate Health Science University, USA. He has extensive experience in clinical and translational research and has led the largest center in North America in the landmark diabetes prevention trial, the DREAM trial using the commonly prescribed ACE-inhibitor ramipril. He has edited several books and authored over 300 publications on diabetes, hypertension, dyslipidemia, cardiovascular disease, and related areas. His work has been among the most read articles with over 10,000 citations in major medical journals. He is the Founding Editor-In-Chief for the International Journal of Clinical Research and Trials and has served as the Editor-In-Chief for several other journals. He is a nationally and internationally recognized scholar who served as a member at the National Institute of Health-NIDDK committee (3x 4- year terms) and as a chair of the NIH-NIDDK U01 review committee (thrice). He has received multiple recognitions including Certificate of Special Congressional Recognition and he also served as District President for the American College of Physicians. He is also a well-recognized mentor with some of his trainees serving in leadership positions at the NIH and other major institutions.